Table 1.
Baseline characteristics of participants in the modified intention-to-treat analysis.a
| Participants | ||||
|---|---|---|---|---|
| Characteristics | Total (N=357) |
Saw Palmetto Extract (n=176) |
Placebo (n=181) |
p value |
| Age, y | 60.97 (8.40) | 61.25 (8.72) | 60.7 (8.08) | 0.54 |
| Race/ethnicity, No. (%) | 0.42 | |||
| White | 284 (79.6) | 145 (82.4) | 139 (76.8) | |
| Black | 41 (11.5) | 17 (9.7) | 24 (13.3) | |
| Hispanic, Latino or otherb | 32 (9.0) | 14 (8.0) | 18 (9.9) | |
| Education, No. (%) | 0.64c | |||
| <High school | 13 (3.6) | 6 (3.4) | 7 (3.9) | |
| High school graduate | 38 (10.6) | 20 (11.4) | 18 (9.9) | |
| Some college | 60 (16.8) | 26 (14.8) | 34 (18.8) | |
| College graduate | 99 (27.7) | 48 (27.3) | 51 (28.2) | |
| Postcollege | 142 (39.8) | 75 (42.6) | 67 (37.0) | |
| No repsonse | 5 (1.4) | 1 (0.6) | 4 (2.2) | |
| PSA level, ng/ml | 2.07 (1.78) | 2.20 (1.95) | 1.93 (1.59) | 0.16 |
Abbreviations: No, number; PSA, prostate-specific antigen; y, year
a
Data are presented as mean (SD) unless otherwise specified.
b
Other included American Indian or Alaska Native, Asian, Native Hawaiian or other Pacific Islander, or unknown or not reported.
c
P value based on Wilcoxon rank sum test.